Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1985 4
1986 2
1992 2
1993 1
1996 2
1997 1
1998 1
1999 2
2000 5
2001 4
2002 4
2003 4
2004 8
2005 3
2006 5
2007 6
2008 6
2009 4
2010 3
2011 4
2012 7
2013 14
2014 10
2015 10
2016 9
2017 3
2018 7
2019 8
2020 4
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.
Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, Drenth JP, Pockros PJ, Regula J, Beuers U, Trauner M, Jones DE, Floreani A, Hohenester S, Luketic V, Shiffman M, van Erpecum KJ, Vargas V, Vincent C, Hirschfield GM, Shah H, Hansen B, Lindor KD, Marschall HU, Kowdley KV, Hooshmand-Rad R, Marmon T, Sheeron S, Pencek R, MacConell L, Pruzanski M, Shapiro D; POISE Study Group. Nevens F, et al. Among authors: pockros pj. N Engl J Med. 2016 Aug 18;375(7):631-43. doi: 10.1056/NEJMoa1509840. N Engl J Med. 2016. PMID: 27532829 Free article. Clinical Trial.
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study.
Bowlus CL, Eksteen B, Cheung AC, Thorburn D, Moylan CA, Pockros PJ, Forman LM, Dorenbaum A, Hirschfield GM, Kennedy C, Jaecklin T, McKibben A, Chien E, Baek M, Vig P, Levy C. Bowlus CL, et al. Among authors: pockros pj. Hepatol Commun. 2023 May 15;7(6):e0153. doi: 10.1097/HC9.0000000000000153. eCollection 2023 Jun 1. Hepatol Commun. 2023. PMID: 37184523 Free PMC article.
Novel therapeutic approaches for hepatitis C.
Au JS, Pockros PJ. Au JS, et al. Among authors: pockros pj. Clin Pharmacol Ther. 2014 Jan;95(1):78-88. doi: 10.1038/clpt.2013.206. Epub 2013 Oct 14. Clin Pharmacol Ther. 2014. PMID: 24126682 Review.
Drug-induced liver injury from antiepileptic drugs.
Au JS, Pockros PJ. Au JS, et al. Among authors: pockros pj. Clin Liver Dis. 2013 Nov;17(4):687-97, x. doi: 10.1016/j.cld.2013.07.011. Epub 2013 Sep 4. Clin Liver Dis. 2013. PMID: 24099025 Review.
Hematologic and oncologic diseases and the liver.
Singh MM, Pockros PJ. Singh MM, et al. Among authors: pockros pj. Clin Liver Dis. 2011 Feb;15(1):69-87. doi: 10.1016/j.cld.2010.09.013. Clin Liver Dis. 2011. PMID: 21111994 Review.
Helminthic infections of the liver.
Pockros PJ, Capozza TA. Pockros PJ, et al. Curr Gastroenterol Rep. 2004 Aug;6(4):287-96. doi: 10.1007/s11894-004-0080-8. Curr Gastroenterol Rep. 2004. PMID: 15245696 Review.
Natural progression of untreated hepatolithiasis.
Pockros PJ. Pockros PJ. J Clin Gastroenterol. 2001 Aug;33(2):95-6. doi: 10.1097/00004836-200108000-00001. J Clin Gastroenterol. 2001. PMID: 11468433 No abstract available.
Ribavirin analogs.
Shields WW, Pockros PJ. Shields WW, et al. Among authors: pockros pj. Clin Liver Dis. 2009 Aug;13(3):419-27. doi: 10.1016/j.cld.2009.05.006. Clin Liver Dis. 2009. PMID: 19628158
SCV-07 (SciClone Pharmaceuticals/Verta).
Aspinall RJ, Pockros PJ. Aspinall RJ, et al. Among authors: pockros pj. Curr Opin Investig Drugs. 2006 Feb;7(2):180-5. Curr Opin Investig Drugs. 2006. PMID: 16499289 Review.
Why do we need another interferon?
Pockros PJ. Pockros PJ. Gastroenterology. 2010 Oct;139(4):1084-6. doi: 10.1053/j.gastro.2010.08.015. Epub 2010 Aug 26. Gastroenterology. 2010. PMID: 20800652 No abstract available.
137 results